Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Are there meaningful biomarkers of treatment response for depression?

Drug discovery today - 1 May 2014

Breitenstein Barbara, Scheuer Sandra, Holsboer Florian

Abstract excerpt

During the past decades, the prevalence of affective disorders has been on the rise globally, with only one out of three patients achieving remission in acute treatment with antidepressants. The identification of physiological markers that predict treatment course proves useful in increasing therapeutic success. On the basis of well-documented, recent findings in depression research, we highlight and discuss the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Biomarkers
Share to Depression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genetic Variation

Share to Treatment of Major Depression

Share to Treatment Outcome

Share to Tryptophan and brain disorders

Source

Identifiers

PMID: 24561326
DOI: 10.1016/j.drudis.2014.02.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Are there meaningful biomarkers of treatment response for depression?PMID 24561326Read ↗

Advances in biomarkers of major depressive disorder.Semantic proximity Read ↗

Advancing Depression Management Through Biomarker Discovery with a Focus on Genetic and Epigenetic Aspects: A Comprehensive Study on Neurobiological, Neuroendocrine, Metabolic, and Inflammatory PathwaysSemantic proximity Read ↗

Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures.Semantic proximity Read ↗

A review of new insights into existing major depressive disorder biomarkersSemantic proximity Read ↗

Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder.Semantic proximity Read ↗

Novel biomarkers in major depressionSemantic proximity Read ↗

Gene expression: Biomarker of antidepressant therapy?Semantic proximity Read ↗

Individualized Treatment Strategy for Depressive Disorder.Semantic proximity Read ↗

A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant PharmacotherapySemantic proximity Read ↗

Treatment-resistant depression: molecular mechanisms and managementSemantic proximity Read ↗

Pharmacogenetic studies in depression: a proposal for methodologic guidelines.Semantic proximity Read ↗

Progress and prospects in pharmacogenetics of antidepressant drugsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.